Abstract Neurodevelopmental disorders including autism spectrum disorder (ASD) affect 5.9% of the global population. Research shows the potential therapeutic use…
Abstract Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by social communication deficits, repetitive behaviors, and sensory abnormalities. Sodium…
Abstract Introduction: Autism spectrum disorder (ASD) is characterized by disruption of the gut–brain axis, which leads to behavioral, psychiatric, metabolic…
Abstract Aim: We developed a living systematic review (LSR) that will continuously map the safety and reported benefit data related…
Abstract Background: Phelan–McDermid syndrome (PMS) is a neurodevelopmental disorder, caused by haploinsufficiency of the SHANK3 gene. In addition to global…
Abstract Autism Spectrum Disorder (ASD) lacks an established pharmacological treatment protocol, prompting interest in alternative therapeutic approaches, such as cannabidiol…
Abstract Background: Autism spectrum disorder (ASD) is a neurodevelopmental disorder commonly associated with behavioral challenges. There are few evidence based…
Abstract Background: Cannabinoids have been of increasing interest mainly due to their putative efficacy in a wide array of psychiatric,…
Abstract Autism spectrum disorder (ASD) is a common neurodevelopmental condition mainly characterized by both a scarce aptitude for social interactions…
Abstract Autism spectrum disorder (ASD) is a neurological disease and lifelong condition. The treatment gap in ASD has led to…